Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.81 AUD
Change Today -0.01 / -1.22%
Volume 2.4M
As of 2:11 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

sigma pharmaceuticals ltd (SIP) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/24/15 - A$1.00
52 Week Low
12/3/14 - A$0.71
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sigma pharmaceuticals ltd (SIP) Related Businessweek News

No Related Businessweek News Found

sigma pharmaceuticals ltd (SIP) Details

Sigma Pharmaceuticals Limited engages in the wholesale and distribution of pharmaceutical products to hospitals and retail pharmacies in Australia. It operates approximately 300 pharmacies under the Amcal name; and 150 pharmacies under the Guardian name. The company also offers health management services, including professional advice; and tailored products in the areas of heart health, bones and joints, diabetes, and respiration under the Amcal Max name. In addition, it manages and promotes a range of over the counter private and exclusive label products made available to brand member customers, as well as a generic range of private label products under the Pharmacy Care range. Sigma Pharmaceuticals Limited was founded in 1912 and is headquartered in Rowville, Australia.

Founded in 1912

sigma pharmaceuticals ltd (SIP) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$1.7M
Chief Financial Officer
Total Annual Compensation: A$602.8K
Chief Operating Officer
Total Annual Compensation: A$680.9K
Compensation as of Fiscal Year 2015.

sigma pharmaceuticals ltd (SIP) Key Developments

Sigma Pharmaceuticals Ltd. Announces Financial Results for the Year 2014

Sigma Pharmaceuticals Ltd. announced financial results for the year 2014. For the year, the company's Revenues were up 5.7% to $3.1 billion. This was achieved from a combination of a 5.3% increase in volumes delivered and the addition of CHS, Pharmasave, Chemist King and Discount Drug Stores part way through the year, which was partly offset by the impact of PBS reform. Earnings before interest and tax was up 11.0% for the year to reach $78.0 million. This result has been achieved through organic growth, the acquisitions made during the year, and a sustained focus on controlling costs.

Sigma Pharmaceuticals Ltd. - Shareholder/Analyst Call

Annual General Meeting 2015

Rhinomed and Sigma Pharmaceuticals Limited Enter into Distribution Agreement

Rhinomed announced it has continued to expand its Australian wholesale pharmacy distribution footprint with Sigma Pharmaceuticals Limited to wholesale its MuteTM snoring and sleep quality technology. This agreement builds on Rhinomed's announcement last month, that national pharmacy distributor Symbion was to support the entry of MuteTM into leading pharmacy chains.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIP:AU A$0.81 AUD -0.01

SIP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SIP.
View Industry Companies

Industry Analysis


Industry Average

Valuation SIP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at